Therefore, we speculate that APS may decrease the secretion of pro-inflammatory cytokines by preventing the initiation of the TLR4/MyD88/NF-κB pathway, which may be the main approach to ameliorate gut inflammation and injury caused by DSS. The gene discussed is MYD88; the disease is autoimmune polyendocrinopathy.